Bio-Nanocapsule-Liposome Conjugates for In Vivo Pinpoint Drug and Gene Delivery

Methods in Enzymology

Volumn 464, Issue C, 2009, Pages 147-166

  Kasuya, Takeshi ^a   Jung, Joohee ^a   Kinoshita, Rie ^b   Goh, Yasumasa ^b   Matsuzaki, Takashi ^a   Iijima, Masumi ^a,c   Yoshimoto, Nobuo ^a,c   Tanizawa, Katsuyuki ^a   Kuroda, Shun'ichi ^a,b,c  

^a OSAKA UNIVERSITY   (Japan)

^b Beacle Inc   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOTIN; CYTOKINE; DNA; DOXORUBICIN; GANCICLOVIR; LECTIN; LIPOPLEX; LIPOPOLYSACCHARIDE; LIPOSOME; NANOCAPSULE; RNA;

CIRCULATION; COLUMN CHROMATOGRAPHY; CONJUGATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; REVIEW; SACCHAROMYCES CEREVISIAE; ULTRACENTRIFUGATION; ANIMAL; ARTICLE; CHEMISTRY; GENE THERAPY; GENE VECTOR; GENETICS; METHODOLOGY; MOLECULAR BIOLOGY; MOUSE;

HEPATITIS B VIRUS; SACCHAROMYCES CEREVISIAE;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENETIC VECTORS; HEPATITIS B VIRUS; HUMANS; LIPOSOMES; MICE; MOLECULAR BIOLOGY; NANOCAPSULES; SACCHAROMYCES CEREVISIAE;

EID: 71549162528     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)64008-8     Document Type: Review

References (37)

1. Bangham A.D., and Horne R.W. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J. Mol. Biol. 8 (1964) 660-668
2. Batzri S., and Korn E.D. Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta 298 (1973) 1015-1019
3. Björck L., and Kronvall G. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J. Immunol. 133 (1984) 969-974
4. Düzgüneş N., Simões S., Pires P., and Pedroso de Lima M.C. Gene delivery by cationic liposome-DNA complexes. In: Dumitriu S. (Ed). Polymeric Biomaterials (2002), Marcel Dekker, New York 943-958
5. Glebe D., and Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J. Gastroenterol. 13 (2007) 22-38
6. Hama S., Akita H., Ito R., Mizuguchi H., Hayakawa T., and Harashima H. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol. Ther. 13 (2006) 786-794
7. Hinnen A., Hicks J.B., and Fink G.R. Transformation of yeast. Proc. Natl. Acad. Sci. USA 75 (1978) 1929-1933
8. Hong R.L., Huang C.J., Tseng Y.L., Pang V.F., Chen S.T., Liu J.J., and Chang F.H. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial?. Clin. Cancer Res. 5 (1999) 3645-3652
9. Iwasaki Y., Ueda M., Yamada T., Kondo A., Seno M., Tanizawa K., Kuroda S., Sakamoto M., and Kitajima M. Gene therapy of liver tumors with human liver-specific nanoparticles. Cancer Gene Ther. 14 (2007) 74-81
10. Jung J., Matsuzaki T., Tatematsu K., Okajima T., Tanizawa K., and Kuroda S. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J. Control. Release 126 (2008) 255-264
11. Kasuya T., and Kuroda S. Nanoparticles for human liver-specific drug and gene delivery systems: In vitro and in vivo advances. Expert Opin. Drug Deliv. 6 (2009) 39-52
12. Kasuya T., Nomura S., Matsuzaki T., Jung J., Yamada T., Tatematsu K., Okajima T., Tanizawa K., and Kuroda S. Expression of squamous cell carcinoma antigen-1 in liver enhances the uptake of hepatitis B virus envelope-derived bio-nanocapsules in transgenic rats. FEBS J. 275 (2008) 5714-5724
13. Kasuya T., Yamada T., Uyeda A., Matsuzaki T., Okajima T., Tatematsu K., Tanizawa K., and Kuroda S. In vivo protein delivery to human liver-derived cells using hepatitis B virus envelope pre-S region. J. Biosci. Bioeng. 106 (2008) 99-102
14. 4 isolectin to malignant tumors overexpressing N-acetylglucosaminyltransferase V. Hum. Gene Ther. 19 (2008) 887-895
15. Kikuchi A., Aoki Y., Sugaya S., Serikawa T., Takakuwa K., Tanaka K., Suzuki N., and Kikuchi H. Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor. Hum. Gene Ther. 10 (1999) 947-955
16. Kobayashi M., Asano T., Utsunomiya M., Itoh Y., Fujisawa Y., Nishimura O., Kato K., and Kakinuma A. Recombinant hepatitis B virus surface antigen carrying the pre-S2 region derived from yeast: Purification and characterization. J. Biotechnol. 8 (1988) 1-22
17. Kurata N., Shishido T., Muraoka M., Tanaka T., Ogino C., Fukuda H., and Kondo A. Specific protein delivery to target cells by antibody-displaying bionanocapsules. J. Biochem. 144 (2008) 701-707
18. Kuroda S., Otaka S., Miyazaki T., Nakao M., and Fujisawa Y. Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J. Biol. Chem. 267 (1992) 1953-1961
19. In: Lasic D., and Martin F. (Eds). Stealth Liposomes (1995), CRC Press, Boca Raton, FL
20. Li S.D., and Huang L. Gene therapy progress and prospects: Non-viral gene therapy by systemic delivery. Gene Ther. 13 (2006) 1313-1319
21. Lorusso V., Manzione L., and Silvestris N. Role of liposomal anthracyclines in breast cancer. Ann. Oncol. 18 (2007) 70-73
22. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release 65 (2000) 271-284
23. Markman M. Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary. Expert Opin. Pharmacother. 7 (2006) 1469-1474
24. Marshall E. Clinical research. Gene therapy a suspect in leukemia-like disease. Science 298 (2002) 34-35
25. Moghimi S.M., and Szebeni J. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42 (2003) 463-478
26. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53 (2001) 283-318
27. Nagaoka T., Fukuda T., Yoshida S., Nishimura H., Yu D., Kuroda S., Tanizawa K., Kondo A., Ueda M., Yamada H., Tada H., and Seno M. Characterization of bio-nanocapsule as a transfer vector targeting human hepatocyte carcinoma by disulfide linkage modification. J. Control. Release 118 (2007) 348-356
28. Parr M.J., Masin D., Cullis P.R., and Bally M.B. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). J. Pharmacol. Exp. Ther. 280 (1997) 1319-1327
29. Richardson M. AmBisome: Adds to the body of knowledge and familiarity of use. Acta Biomed. 77 (2006) 3-11
30. Rosenthal E., Poizot-Martin I., Saint-Marc T., Spano J.P., Cacoub P., and DNX Study Group. Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma. Am. J. Clin. Oncol. 25 (2002) 57-59
31. Savulescu J. Harm, ethics committees and the gene therapy death. J. Med. Ethics 27 (2001) 148-150
32. Szoka Jr. F., and Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 75 (1978) 4194-4198
33. Takayama M., Itoh S., Nagasaki T., and Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin. Chim. Acta 79 (1977) 93-98
34. Tsutsui Y., Tomizawa K., Nagita M., Michiue H., Nishiki T., Ohmori I., Seno M., and Matsui H. Development of bionanocapsules targeting brain tumors. J. Control. Release 122 (2007) 159-164
35. Yamada T., Iwabuki H., Kanno T., Tanaka H., Kawai T., Fukuda H., Kondo A., Seno M., Tanizawa K., and Kuroda S. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein. Vaccine 19 (2001) 3154-3163
36. Yamada T., Iwasaki Y., Tada H., Iwabuki H., Chuah M.K., VandenDriessche T., Fukuda H., Kondo A., Ueda M., Seno M., Tanizawa K., and Kuroda S. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat. Biotechnol. 21 (2003) 885-890
37. Yu D., Amano C., Fukuda T., Yamada T., Kuroda S., Tanizawa K., Kondo A., Ueda M., Yamada H., Tada H., and Seno M. The specific delivery of proteins to human liver cells by engineered bio-nanocapsules. FEBS J. 272 (2005) 3651-3660